Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-03-15
1995-07-25
Warden, Jill
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530300, 530324, 514826, 514886, A61K 3800, A61K 3802, C07K 500, C07K 700
Patent
active
054362229
ABSTRACT:
A method of treating an inflammatory disease in a mammal, e.g., a human, by inhibiting pro-inflammatory mediator release from basophils or mast cells in the human, by administering to the human a therapeutically effective amount of purified or recombinant platelet factor 4 (PF4), a PF4 analog, or a peptide fragment of PF4 or the analog.
REFERENCES:
Brindley et al, J. Clin. Invest, vol. 72, pp. 1218-1223, (1983).
Averill et al., Am. Rev. Respir. Dis., vol. 145, No. 2, Feb. 1992, pp. 571-576.
Knauer et al., Int. Archs Allergy appl. Immun. vol. 74, pp. 29-35, 1984.
Alam et al., J. Clin. Invest., 89:723 (1992).
Alam et al., J. Clin. Invest., 82:2056 (1988).
Bischoff et al., Biochem. Biophys. Res. Commun., 179:628-33 (1991).
Fisher et al., J. Allergy Clin. Immunol., 91(1):Abstracts 225, No. 339 (1992).
Fisher et al., J. Allergy Clin. Immunol., 89(1):Abstracts 165, No. 81 (1992).
Goetzl et al., J. Exp. Med., 158:731-737 (1983).
Hirai et al., J. Immunol., 141:3958 (1988).
Hirai et al., J. Exp. Med., 172:1525 (1990).
Irvin, J. Allergy Clin. Immunol., 90(3):521-533 (1992).
Knauer et al., N. Engl. J. Med., 304:1404 (1981).
Koch et al., J. Clin. Invest., 90:772 (1992).
Kuna et al., J. Allergy Clin. Immunol., 91: Abstracts 314, No. 695 (1993).
Kuna et al., J. Immunol., 149:636 (1992).
Kuna et al., J. Immunol. 147:1920-1924 (1991).
Kuna et al., J. Immunol. 150:1932-1943 (Mar., 1993).
Kuna et al., J. Exp. Med., 175:489 (1992).
Maione et al., Science, 247:77-79 (1990).
McFadden, et al., Chap. 257 "Asthma," Harrison's Principles of Internal Medicine, 1349-1354 (McGraw-Hill, Inc. 1977).
Metzger et al., J. Allergy Clin. Immunol., 91(1):Abstracts 163, No. 89 (1983).
Metzger et al., Chapter 35, "Late Phase Asthma in an Allergic Rabbit Model", pp. 347-362.
Osterman et al., Biochem. and Biophys. Res. Comm., 107(1):130-135 (1982).
Wasserman et al., J. Allerg Clin. Immunol., 74:275-279 (1984).
Kaplan Allen P.
Kuna Piotr
Davenport A. M.
The Research Foundation of State University of New York
Warden Jill
LandOfFree
Use of platelet factor 4 to treat inflammatory diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of platelet factor 4 to treat inflammatory diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of platelet factor 4 to treat inflammatory diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-739651